Published Date: 16 Mar 2023
In Part 1 of the Obesity Series, Katherine H. Saunders, MD, DABOM discusses ways to treat childhood obesity, including the benefits of FDA-approved drugs and Intellihealth.
Read Full NewsPhase 3 data show dapirolizumab pegol improved remission and disease stability in lupus; a second trial and patient-reported outcomes are now underway.
Acumen Pharmaceuticals initiates a phase 2 trial extension for sabirnetug, targeting early Alzheimer disease and aiming for long-term safety insights.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending November 21, 2025.
A case report reveals cognitive decline and brain atrophy in a patient with NMOSD, highlighting potential subclinical neurodegeneration despite limited relapses.
A recent study confirms satralizumab's long-term safety and efficacy for treating neuromyelitis optica spectrum disorder, supporting its use as a maintenance therapy.
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is neural network plasticity after stroke!
At ACAAI 2025, Howell discussed sub-analytical data showing early itch and skin improvements with tapinarof cream in children with AD aged 2–17 years.
1.
Obesity-related cancer rising among both younger and older adults worldwide, study finds
2.
Future of Lab-Developed Tests Still Taking Shape
3.
Study identifies new approach to protect the brain during radiation therapy
4.
Study finds higher breast cancer rates in areas with more air pollution
5.
Top Options Are Discovered Through Direct Comparison of 25 Migraine Drugs.
1.
Unlocking the Potential of Glofitamab: A Novel Treatment for Cancer
2.
CAR-T Cell Therapy for Diffuse Large B-Cell Lymphoma: A Comprehensive Review
3.
Ultrasound: A Promising Tool in the Fight Against Malignant Breast Cancer
4.
Understanding Protein C Deficiency: Symptoms, Causes, and Treatment
5.
Unlocking the Potential of Ferrotonia: A New Way to Harness Magnetic Energy
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Efficient Management of First line ALK-rearranged NSCLC - Part V
2.
CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC
3.
Navigating the Complexities of Ph Negative ALL - Part III
4.
Virtual Case Study on Pedal Edema and Triple Vessel Disease - An Initiative by Hidoc Dr.
5.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation